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 ORIGINAL ARTICLE 
 Effect of  “ motivational interviewing ” on quality of care measures in 
screen detected type 2 diabetes patients: A one-year follow-up of an 
RCT, ADDITION Denmark 
 SUNE  RUBAK 1,2 ,  ANNELLI  SANDB Æ K 3 ,  TORSTEN  LAURITZEN 3 , 
 KNUT  BORCH-JOHNSEN 4,5  &  BO  CHRISTENSEN 3 
 1 Department General Practice and Research Unit of General Medical Practice. Institute of Public Health University of Aarhus, 
 2 Department of Paediatrics, Skejby Hospital,  3 Department General Practice. Institute of Public Health, University of Aarhus, 
 4 Steno Diabetes Center,  5 The Faculty of Health Sciences, University of Aarhus, Denmark 
 Abstract 
 Objective.  “ Motivational interviewing ” (MI) has shown to be broadly applicable in the management of behavioural problems 
and diseases. Only a few studies have evaluated the effect of MI on type 2 diabetes treatment and none has explored the 
effect of MI on target-driven intensive treatment.  Methods. Patients were cluster-randomized by GPs, who were randomized 
to training in MI or not. Both groups received training in target-driven intensive treatment of type 2 diabetes. The inter-
vention consisted of a 1 ½ -day residential course in MI with half-day follow-up twice during the fi rst year. Blood samples, 
case record forms, national registry fi les, and validated questionnaires from patients were obtained.  Results. After one year 
signifi cantly improved metabolic status measured by HbA1c (p   0.01) was achieved in both groups. There was no differ-
ence between groups. Medication adherence was close to 100% within both treatment groups. GPs in the intervention 
group did not use more than an average of 1.7 out of three possible MI consultations.  Conclusion. The study found no 
effect of MI on metabolic status or on adherence of medication in people with screen detected type 2 diabetes. However, 
there was a signifi cantly improved metabolic status and excellent medication adherence after one year within both study 
groups. An explanation may be that GPs in the control group may have taken up core elements of MI, and that GPs trained 
in MI used less than two out of three planned MI consultations. The fi ve-year follow-up of this study will reveal whether 
MI has an effect over a longer period. 
 Key Words:  Alcohol abuse ,  blood pressure ,  Body Mass Index ,  motivational interviewing ,  type 2 diabetes 
 Research regarding the intensive multi-factorial 
treatment of Type 2 diabetes patients has almost 
exclusively been conducted in the secondary health 
care system, in hospital settings [1,2]. A major 
problem in these studies has been poor patient 
adherence to healthy lifestyle and poor adherence 
to medication [1,2]. New approaches to achieve 
behavioural changes are therefore required.  “ Moti-
vational interviewing ” (MI) is one of the rather 
well-documented, scientifi cally tested methods of 
client counselling developed by Miller and Rollnick 
and it is viewed as a useful intervention strategy 
for changing behaviour and improving disease 
 management [3]. MI has been used in very few 
studies of type 2 diabetes and the results have been 
varying [4 – 8]. People with type 2 diabetes in Den-
mark are primarily treated in the primary health 
care system. No investigations have evaluated the 
effect of MI in relation to target-driven intensive 
treatment of people with type 2 diabetes detected 
by screening in primary care. The aim of this study 
is to evaluate whether a course in MI for general 
practitioners (GPs) improves patient adherence to 
intensive treatment based on risk parameters and 
adherence to prescribed medication in people with 
type 2 diabetes detected by screening. 
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 Material and methods 
 Study group 
 This randomized controlled trial is a sub-study of the 
ADDITION study [9], which is a multi-centre ran-
domized controlled trial of a target-driven approach 
to intensive treatment of 40- to 69-year-old people 
with screen-detected type 2 diabetes. Inclusion and 
exclusion criteria followed the ADDITION study [9]. 
All patients newly diagnosed with type 2 diabetes in 
the screening study were eligible to participate, unless 
they were found to have: contraindications or intoler-
ance to study medication; a history of alcoholism, 
drug abuse, psychosis, or other emotional problems 
likely to invalidate informed consent or adherence to 
treatment; malignant disease with a poor prognosis; 
were pregnant or lactating. 
 This study included practices/GPs from the 
intensive arm of ADDITION Denmark from two 
counties in DK (Figure 1) randomized by the project 
manager using the method  “ drawing lots ” into  an 
intervention group (I-group) comprising GPs who 
completed an MI training course and  a control group 
(C-group) of GPs who received no formal training in 
MI. Randomization was stratifi ed by county, size of 
practices, and by numbers of full-time GPs. 
 In order to determine sample size, a power anal-
ysis was performed [10]. The inclusion and dropout 
of the GPs and patients are shown in the fl owchart, 
Figure 1. 
 Method of intervention 
 The courses in  “ motivational interviewing ” (MI) for 
the GPs in the I-group were conducted by a trained 
teacher introducing a manual [11] which together 
with  “ Motivational interviewing, preparing people 
to change addictive behaviour ” [3] constituted the 
theoretical part of the course curriculum. The 
I-group was coached in the key points of MI [3]. 
The training also included the use of specifi c skills, 
e.g. empowerment [12], ambivalence [3], the deci-
sional balance schedule [3], the visual analogue scale 
[3], stage of change [13], and refl ective listening [3], 
all of which are described in detail in the book MI 
[3]. The I-group courses consisted of a 1 ½ -day 
training sessions with a half-day follow-up twice 
during the fi rst year. None of the GPs in I- and 
C-group had previously participated in an MI course. 
All GPs in the I- and the C-group participated in 
 Previous studies show a signifi cant effect of 
 “ motivational interviewing (MI) ” in a broad 
area of diseases through changing patients ’ 
self-effi cacy in terms of their understanding of 
the disease, their beliefs regarding treatment 
and prevention aspects, and their motivation 
for changing behaviour. 
 This study shows signifi cantly improved  •
metabolic status after one year in people 
with screen-detected type 2 diabetes regard-
less of whether they received MI. Specifi c 
reasons for not achieving an effect of MI 
are discussed. 
 Important factors for a lacking effect may be  •
the fact that GPs in the control group have 
taken up some of the core concepts of MI 
and that GPs trained in MI used less than 
two out of three planned MI consultations. 
Randomisation
(stratified by county and size of practice) 
Eligible practices willing to participate
N = 80 (including 140 GPs)
Control group, C-group
N = 43 (76 GPs) 
GPs received residential course in
Motivational interviewing  
GPs received residential course in intensive treatment of Type 2 diabetes
Follow protocol, guidelines, case record forms and patient material
Inclusion of patients according to inclusion-/exclusion criteria
GPs meeting at follow up days, ½ a
day twice during the first year
Patients included with one year follow-up
N = 307 T2D in I-group N = 321 T2D in C-group**
Intervention group, trained in
Motivational interviewing.
 I-group, N = 37 (64 GPs)
GPs included with one year follow-up
Control group, C-group
N = 41 (70 GPs)* 
Intervention group, I-group
N = 37 (64 GPs)
View Table 1 to see data rates on all data in I-and C-group
*2 practices (6 GPs) dropped out after randomisation
**2 Type 2 diabetes patients dropped out after randomisation
Figure 1. Flowchart of included general practitioners (GPs) and 
screen-detected type 2 diabetes patients (T2D)
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the same half-day course on intensive treatment of 
type 2 diabetes. During these diabetes training ses-
sions, it was stressed that GPs should act as counsel-
lors for the patients, allowing treatment decisions to 
be based on mutual understanding between the 
patient and the GP. In Denmark, GPs ’ consultation 
encounters average 15 minutes and the County 
Health Insurance has agreed to one longer preven-
tive consultation encounter of 45 minutes per patient. 
In this study the County Health Insurance agreed 
to allow the GPs in the I- and C-group to undertake 
three consultations of 45 minutes per patient, in 
which the I-group could use MI. 
 Measurements 
 The intervention phase began on 1 May 2001. The 
study was based on the following data obtained at 
baseline and one-year follow-up: 
 Risk profi le. HbA1c was analysed using a BioRad 
Variant  TM and serum cholesterol/HDL-cholesterol/
triglycerides were analysed using a Hitachi 912. 
LDL-cholesterol was calculated using Fridewald ’ s 
formula. All blood samples were analysed according 
to the Danish quality assurance for laboratories. 
 Height was measured to the nearest 0.1 cm using 
a fi xed rigid stadiometer. Participants ’ weight in light 
indoor clothing was measured to the nearest 0.1 kg 
with a SECA scale. Blood pressure (systolic and dia-
stolic) was measured at rest at the GP ’ s surgery. 
 Health care services. Prescribed medication was 
reported by the GPs on case record forms. The num-
ber of prescriptions cashed in at the pharmacy by the 
patient was drawn from the National Health Service 
Registry. The number of encounters and blood sam-
ples was obtained from register data fi les from the 
National Health Service Registry. 
 Self-reported data. Data on smoking and exercise 
in leisure time and at work were obtained from 
patient questionnaires. 
 The questions on physical activity had previously  •
been validated in the  “ International Physical 
Activity Questionnaire (IPAQ) ” [14]. 
 The questions on smoking had previously been  •
validated in the  “ Summary of Diabetes Self-Care 
Activities ” (SDSCA) questionnaire [15,16]. 
 Answer categories for the questions were dichoto-
mized (yes/no) or presented on continuous scales ( “ On 
how many of the last 7 days did you ...? ” ). The ques-
tionnaires were designed and processed in Teleform. 
 Overall endpoints are described in detail in the 
ADDITION study [9], from which this study included 
the  “ intermediate endpoints ” and  “ process-of-care 
endpoints ” . 
 Statistical methods 
 Statistical analysis of data was conducted in SPSS. 
Results are either given as median and range, as sim-
ple percentages, or as mean and 95% confi dence 
interval (CI). A paired t-test was used to compare 
changes from 0 to 12 months. A statistical signifi cance 
level of 0.05 (two tailed) was used. A non-parametric 
Mann – Whitney test was used for variables not distrib-
uted by normal variation. The clustering within GPs 
was adjusted for by using a mixed regression model 
assuming random variation between and within GPs. 
The power calculation took into account the cluster 
design with ICC for the outcomes of 0.05, which is a 
conservative estimate for intermediate outcomes in 
primary health care. In the power analysis SPSS Sam-
ple Power Two Sample Proportion was used. After 
correction of cluster sampling it was concluded at that 
time that the study would show effect (95% CI) of 
 “ motivational interviewing ” , if a minimum 19% of 
patients reached normal HbA1c (HbA1c below 6.4). 
 Results 
 A fl owchart for participating practices (GPs) and 
patients can be seen in Figure 1. In all, 80 practices 
(140 GPs) were included. The 37 practices (64 GPs) 
were randomized into the I-group and 43 practices 
(76 GPs) into the C-group. Two practices (six GPs) 
and two patients dropped out after randomization. 
All GPs in the I-group participated in the educa-
tional and training courses, and less than 10% were 
absent from the half-day follow-up meetings. The 
study included: 628 type 2 diabetes patients with a 
one-year follow-up, 321 in the C-group and 307 in 
the I-group. Among the 628 patients, 58% were 
male; average age was 61 years with no signifi cant 
differences between the groups. The response rate to 
the patient questionnaire was 87% in the I-group and 
90% in the C-group. According to the case record 
forms, 78% of patients in the I-group and 75% in 
the C-group had visited their GP one year after their 
inclusion in the study. Blood sample results were 
obtained from all patients. 
 Measures for the risk profi le at 0 and 12 months 
are presented in Table I. The number of patients 
within the treatment targets and BMI   27 at study 
entry and after one year is seen in Table II. A statis-
tically signifi cant improvement regarding blood pres-
sure, blood lipid measurements, HbA1c, and BMI is 
seen in both groups from 0 to 12 months with no 
signifi cance differences between study groups. Table II 
also shows the patients ’ use of health care services in 
general practice within one year, i.e. number of con-
sultations, blood samples etc. with no significant 
differences between study groups. 
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 The ratios between the proportion of patients 
reported by GPs to have had a prescription for blood 
glucose lowering drugs, BP or lipid lowering drugs, 
and the proportion of patients registered to have 
 “ cashed in ” a prescription for each of the three treat-
ments at the pharmacy did not differ statistically sig-
nifi cantly, either within or between the I- or the 
C-group (Table III). 
 Discussion 
 Statement of principal fi ndings 
 The study showed at one-year follow-up no effect of 
MI on the risk profi le of patients with type 2 diabe-
tes detected by screening. However, significant 
changes in patient outcome including improved met-
abolic status were demonstrated after one year within 
both treatment groups. An explanation of lack of dif-
ference may be that GPs in the control group may 
have taken up core elements of MI, and that GPs in 
the intervention group used less than two out of three 
planned MI consultations. 
 Strengths and weaknesses of the study 
 The validity of the study is strong by virtue of (1) the 
attendance of all GPs on courses intended for each 
group, (2) the absence of less than 10% of GPs from 
the follow-up meetings, (3) a patient response rate to 
the questionnaire exceeding 87%, (4) acquisition of 
78% of the case record forms from GPs in the I-group 
and 75% from GPs in the C-group, and (5) acquisition 
of a 100% data rate from the National Health Service 
Registry and a 100% data rate of blood samples. 
 We cluster randomized at practice level and 
included enough practices to ensure similar distribu-
tions in study groups, and used stratifi ed randomiza-
tion of GPs on size of practice and on county in order 
to obtain high internal validity and a low degree of 
selection bias. This study may suffer from a limitation 
because training in MI was performed by only one 
person. This makes outcome highly dependent on 
this person ’ s teaching methods and capacity to train 
the GPs [5]. We evaluated the course and found GPs 
in the I-group adhered more to the methods of MI 
than GPs in the C-group [5]. 
 Strength and weakness in relation to other studies, 
meaning of the study, unanswered questions 
 Adherence to prescribed medication was high com-
pared with previous studies [17 – 19] despite intensive 
poly-pharmacological treatment. No signifi cant dif-
ferences between the groups were found, however. 
This may be the result of the intensive training of 
GPs in both groups in treatment of type 2 diabetes, 
stressing the importance of GPs acting as counsel-
lors. This hypothesis is supported by a previous paper 
from this study on how MI infl uences GPs ’ profes-
sional behaviour [5]. In summary the effect of MI 
may have been reduced because GPs in the C-group 
had a greater awareness of all aspects of type 2 
diabetes treatment, including motivating lifestyle 
changes. The lacking effect of MI may also be ascribed 
to the fact that GPs trained in MI used less than two 
out of three planned MI consultations. 
 The results revealed that a large proportion of the 
patients in both groups had values (e.g. HbA1c, 
lipid-profi le, blood pressure, or BMI) that were, in 
 Table I. Risk profi le measures at 0- and 12-month follow-up. 
Value Group
Total values p-value
I-group 
(n   307)
C-group 
(n   321)
I- vs. C-group 
(n   307/321)
Time (months) n/n total 0 mean  Δ 0 – 12 mean n 0 mean  Δ 0 – 12 Mean Time 0 – 12
Systolic BP 240/307 140.3  – 6.4 ∗ 240/321 138.9  – 5.8 ∗ ns
Diastolic BP 240/307 83.6  – 3.8 ∗ 240/321 82.7  – 3.4 ∗ ns
T-Chol (blood total cholesterol (mmol/l)) 307/307 5.5  – 0.9 ∗ 321/321 5.5  – 0.9 ∗ ns
HDL (high-density lipoproteins (mmol/l)) 307/307 1.3 0.1 ∗ 321/321 1.3 0.1 ∗ ns
LDL (low-density lipoproteins (mmol/l)) 307/307 3.1  – 0.6 ∗ 321/321 3.2  – 0.7∗ ns
Tgly (triglyceride (mmol/l)) 307/307 1.9  – 0.3 ∗ 321/321 2.2  – 0.3 ∗ ns
HbA1c (% GHb) 307/307 6.9  – 0.7 ∗ 321/321 6.8  – 0.7 ∗ ns
BMI (Body Mass Index) 230/307 30.5  – 0.8 ∗ 238/321 30.8  – 0.9 ∗ ns
% Number of non-smokers 270/307 66.1 6.6 276/321 71.2 7.8 ns
Number of days per week with hard physical 
activity (example: aerobics)
264/307 3.3 0.9 276/321 3.5 0.5 ns
Number of days per week with moderate 
physical activity (example: bicycling in 
moderate tempo)
264/307 4.2 0.6 276/321 3.8 0.7 ns
 Notes:  ∗ p   0.01. ns   no statistically signifi cant difference. 
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 Table II. Patients below treatment target and BMI   27 after one year/patients ’ use of health care services in general practice 
within one year. 
Time Group
Achieved treatment goal at time 0 months p-value
I-group (n   307) 
% of total n
C-group (n   321) 
% of total n I- vs C-group Time 0 months
SBT 39% 44% ns
DBT 59% 66% ns
Cholesterol 21% 23% ns
HbA1c 66% 69% ns
BMI 21% 25% ns
Achieved treatment goal at time 12 months I- vs C-group Time 12 months
SBT 45% 47% ns
DBT 59% 62% ns
Cholesterol 49% 49% ns
HbA1c 83% 82% ns
BMI 20% 24% ns
Patients ’ use of health care services in general practice within one year
Group I-group C-group p-value
No. ordinary consultation ∗ 6.5 (1.0 – 20.0) 6.0 (1.0 – 14.0) ns
No. preventive consultation ∗ 1.5 (1.0 – 2.0) 1.0 (1.0 – 1.0) ns
No. telephone consultation 5.5 (1.0 – 12.0) 8.0 (1.0 – 27.0) ns
No. blood samples ∗ ∗ 3.7 4.5 ns
No. blood glucose ∗ ∗ 4.3 6.7 ns
 Notes: ns   no statistical signifi cant difference, p   0.05.  ∗ median (range) number consultations per patient per GP;  ∗ ∗ mean number telephone 
consultations per patient per GP. Study treatment targets: SBT   135 (systolic blood pressure (mmHg)); SBT   85 (diastolic blood pressure 
(mmHg)); T-chol   5.0 (blood total cholesterol (mmol/l)); HbA1c   6.4 (% Glycolated Hb); BMI   27 (Body Mass Index). 
fact, within the treatment goals from the beginning 
of the study. This left only little room for demonstrat-
ing an effect of MI due to the narrowness of the 
intervention fi eld. 
 Implications for future research or clinical practice 
 Previous studies using MI in general practice have 
demonstrated MI to be effective [8,20 – 24]. How-
ever, only a few studies have focused on how to 
implement MI in the daily clinical work in general 
practice in such a way that it is ascertained that the 
method is used after study closure [25,26]. They 
concluded that it was possible to implement the use 
of MI in general practice although barriers existed 
[5,25,26]. 
 We have previously shown [10] that (1) an MI 
course seemed to infl uence GPs ’ professional behav-
iour, (2) GPs reported that they used MI in their 
daily practice, and (3) that patients changed contem-
plation of behaviour [5,6]. The lacking effect of MI 
on risk profi le in this study may be a result of the 
study ’ s attempt to accomplish too much over too 
short a period. 
 Two recent meta-analyses concluded that psy-
chological therapies improve long-term glycaemic 
control, and that MI had an effect on lifestyle factors 
such as food intake, smoking, alcohol consumption, 
and medication adherence [4,27]. These meta-anal-
yses as well as the results from this study [4 – 6] indi-
cate a need for long-term evaluation of the effect of 
MI on the risk profi le. 
 Table III. Adherence to prescribed medication: Prescriptions  “ cashed in ” by patients at the pharmacy compared with 
prescriptions registered by the GPs after one year (% of patients). 
Medicine % of 
patients in group
I-group (n   307) C-group (n   321)
I- vs C-group 
p-value% ∗ % ratio % ∗ % ratio
Anti-hypertensives 64%/64% 1 63%/63% 1 ns
Lipid-lowering medication 43%/43% 1 47%/47% 1 ns
Anti-thrombotics 54%/64% 0.84 56%/63% 0.88 ns
Oral anti-diabetics 37%/39% 0.96 36%/36% 1 ns
 Notes: ns   no statistical signifi cant difference, p   0.05.  ∗ X% of patients cashed in a prescription for medication/Y% of patients had 
registered a prescription for medication from the GP. 
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 Conclusion 
 The study showed at one-year follow-up no effect of 
MI on the risk profi le of patients with type 2 diabetes 
detected by screening. However, signifi cant changes 
in patient outcome including improved metabolic 
status and medication adherence were demonstrated 
after one year within both treatment groups. An 
explanation may be that GPs in the control group 
may have taken up core elements of MI, and that 
GPs in the intervention group used less than two out 
of three planned MI consultations. Whether more 
intensive training of GPs in MI and whether closer 
contact between the GPs and patients are needed 
require new studies. 
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